Campaigning & Advocacy

As a charity we are actively involved in campaigning on behalf of patients and their carers, which we feel is an important part of the work that we do. We are passionate about doing everything we can to improve the experience of patients throughout their cancer journey.

Our campaigns

We run campaigns throughout the year, and need you to get involved and help raise awareness.

What is campaigning and advocacy?

As a charity we are actively involved in campaigning on behalf of patients and their carers, which we feel is an important part of the work that we do. We are passionate about doing everything we can to improve the experience of patients throughout their cancer journey.

Patient Advocacy Groups

We are involved with a number of organisations and coalitions on your behalf which, through collaborative working, aim to ensure that the collective voice of blood cancer patients is heard.

Working with the pharmaceutical industry

We work with the pharmaceutical industry to ensure that they take the interests of patients into account when developing new drugs and treatments for blood cancer patients.

Health Technology Appraisals

This involves working with bodies such as the National Institute for Health and Care Excellence (NICE), the Scottish Medicines Consortium (SMC) and the All Wales Medicines Strategy Group (AWMSG) to ensure that the views of patients are taken into account when making decisions over access to drugs and treatments.

Leukaemia Care Travel Insurance with AllClear

We’ve partnered with AllClear, a specialist in providing comprehensive travel insurance for people with pre-existing medical conditions like leukaemia.

Read More

Take a Moment to Catch Up

View our latest news and blog articles

June 9th

Dalata and Leukaemia Care extend transformative partnership to 2028

Dalata’s Difference Makers aim to raise over €1 million for health and wellbeing charities...

June 9th

Ruxolitinib approved for patients with acute GvHD in England and Scotland

Leukaemia Care welcomes NICE and the SMC’s approval of ruxolitinib for patients with acute graft versus host disease (aGvHD) in England and Scotland....

March 18th

Welfare Reforms and leukaemia patients: What you need to know

The UK Government's proposed welfare reforms could negatively impact leukaemia patients relying on benefits like Universal Credit and PIP. Leukaemia Care is advocating against unfair changes that may worsen financial struggles. While some aspects remain uncertain, the charity is pushing for fairer policies and offering support to affected individuals....